Viewing Study NCT03127735

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:29 PM
Ignite Modification Date: 2026-02-25 @ 8:27 PM
Study NCT ID: NCT03127735
Status: COMPLETED
Last Update Posted: 2019-05-14
First Post: 2017-04-06
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)
Sponsor: Bayer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia, Myeloid, Acute View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase 1 View
None mIDH1 View
None IDH1 mutation View
None mIDH1 inhibitor View